| Date Filed | Type | Description |
| 06/16/2023 |
4
| Peterson Kristine (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 13,090 restricted stock units
@ $0
Granted 19,597 options to buy
@ $0 |
|
| 03/06/2023 |
4
| Peterson Kristine (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 10,800 options to buy
@ $47.72, valued at
$515.4k
|
|
| 02/09/2023 |
4
| Peterson Kristine (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2022 |
4
| Peterson Kristine (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 7,500 options to buy
@ $68.22, valued at
$511.7k
|
|
| 02/18/2022 |
4
| Peterson Kristine (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
4
| Peterson Kristine (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 7,500 options to buy
@ $49.92, valued at
$374.4k
|
|
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Peterson Kristine (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 17,000 restricted stock units
@ $0
Granted 50,000 options to buy
@ $4.56, valued at
$228k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2020 |
4
| Peterson Kristine (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 10,000 options to buy
@ $51.04, valued at
$510.4k
|
|
| 02/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2019 |
4
| Peterson Kristine (Director) has filed a Form 4 on AMARIN CORP PLC\UK|
Txns:
| Granted 9,658 options to buy
@ $16.83, valued at
$162.5k
Granted 7,428 restricted stock units
@ $0 |
|
| 03/01/2019 |
4
| Peterson Kristine (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 5,000 options to buy
@ $102.54, valued at
$512.7k
|
|
| 02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2018 |
4
| Peterson Kristine (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Granted 26,667 options to buy
@ $1.95, valued at
$52k
Granted 6,667 restricted stock units
@ $0
Granted 40,000 options to buy
@ $1.95, valued at
$78k
|
|
| 06/22/2018 |
4
| Peterson Kristine (Director) has filed a Form 4 on IMMUNOGEN INC|
Txns:
| Granted 4,000 restricted stock units
@ $0
Granted 18,000 options to buy
@ $11.21, valued at
$201.8k
|
|
| 03/05/2018 |
4
| Peterson Kristine (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 3,750 options to buy
@ $78.62, valued at
$294.8k
|
|
| 02/16/2018 |
4
| Peterson Kristine (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 7,500 shares
@ $0
Granted 5,000 options to buy
@ $0 |
|
| 12/19/2017 |
4
| Peterson Kristine (Director) has filed a Form 4 on pSivida Corp.|
Txns:
| Granted 40,000 options to buy
@ $1.77, valued at
$70.8k
|
|
| 09/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2017 |
3
| Peterson Kristine (Director) has filed a Form 3 on ENANTA PHARMACEUTICALS INC |
| 06/30/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|